2003
Progress in the understanding of the pathology and pathogenesis of cutaneous drug eruptions : implications for management. Am J Clin Dermatol. 2003;4(6):407-28.
Lymphoid malignancies: immunophenotypic analysis. Adv Clin Chem. 2003;37:293-353.
The antiphospholipid syndrome. Annu Rev Med. 2003;54:409-24.
The role of the ubiquitination-proteasome pathway in breast cancer: use of mouse models for analyzing ubiquitination processes. Breast Cancer Res. 2003;5(1):16-22.
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. Blood. 2003;101(5):1919-27.
Cytopathologic findings in breast masses in men with HIV infection. Acta Cytol. 2003;47(2):183-7.
BRAF gene is not mutated in plasma cell leukemia and multiple myeloma. Leukemia. 2003;17(11):2238-40.
The utility of the in situ detection of T-cell receptor Beta rearrangements in cutaneous T-cell-dominant infiltrates. Diagn Mol Pathol. 2003;12(3):133-41.
Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma. J Clin Oncol. 2003;21(16):3051-9.
Genetic inactivation of Par4 results in hyperactivation of NF-kappaB and impairment of JNK and p38. EMBO Rep. 2003;4(3):307-12.